Literature DB >> 8195207

A novel member of the immunoglobulin gene superfamily expressed in rat carcinoma cell lines.

C Chadéneau1, B LeMoullac, M G Denis.   

Abstract

Defined by monoclonal antibody E4, the pE4 antigen is a 66,000-Da glycoprotein which is expressed at the cell surface of rat colon and mammary carcinomas, but only in trace amounts in normal adult rat tissues. To determine the structure of this tumor-associated antigen and to identify its functional domains, we have cloned a cDNA coding for this protein. It encodes a 416-amino acid protein with an expected molecular weight for the core protein of approximately 42,000. The predicted amino acid sequence reveals that pE4 contains the conserved amino acids and domain structures characteristic of members of the immunoglobulin gene superfamily. Comparison of this sequence with data banks revealed a significant homology with the human and mouse receptors for polio-virus. However, pE4 is not the rat receptor for poliovirus, as different patterns were obtained by hybridization of rat genomic DNA with both probes. A major approximately 2.2-kilobase transcript of the pE4 gene was detected in all the rat tumor cell lines tested. In contrast, barely detectable levels of pE4 mRNA were found in normal adult rat tissues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195207

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.

Authors:  Satoshi Kawano; Wataru Ikeda; Megumi Kishimoto; Hisakazu Ogita; Yoshimi Takai
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

2.  Isolation and chromosomal location of mE4, a novel murine gene of the immunoglobulin superfamily.

Authors:  C Chadéneau; B LeMoullac; M LeCabellec; M Mattei; K Meflah; M G Denis
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

3.  The Tage4 gene maps to rat chromosome 1q22.

Authors:  C Chadéneau; T Liehr; B Rautenstrauss; M G Denis
Journal:  Mamm Genome       Date:  1997-02       Impact factor: 2.957

4.  Mapping of two different alpha-1,2-fucosyltransferase genes to rat chromosome 1q22-q31.

Authors:  T Liehr; F Hallouin; B Rautenstrauss; J LePendu; M G Denis
Journal:  Mamm Genome       Date:  1997-04       Impact factor: 2.957

5.  Defects in nuclear and cytoskeletal morphology and mitochondrial localization in spermatozoa of mice lacking nectin-2, a component of cell-cell adherens junctions.

Authors:  M J Bouchard; Y Dong; B M McDermott; D H Lam; K R Brown; M Shelanski; A R Bellvé; V R Racaniello
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

6.  Poliomyelitis in transgenic mice expressing CD155 under the control of the Tage4 promoter after oral and parenteral poliovirus inoculation.

Authors:  Shaukat Khan; Hidemi Toyoda; Melissa Linehan; Akiko Iwasaki; Akio Nomoto; Günter Bernhardt; Jeronimo Cello; Eckard Wimmer
Journal:  J Gen Virol       Date:  2014-04-30       Impact factor: 3.891

7.  Overexpression of the CD155 gene in human colorectal carcinoma.

Authors:  D Masson; A Jarry; B Baury; P Blanchardie; C Laboisse; P Lustenberger; M G Denis
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

8.  Inhibition of cell movement and proliferation by cell-cell contact-induced interaction of Necl-5 with nectin-3.

Authors:  Tsutomu Fujito; Wataru Ikeda; Shigeki Kakunaga; Yukiko Minami; Mihoko Kajita; Yasuhisa Sakamoto; Morito Monden; Yoshimi Takai
Journal:  J Cell Biol       Date:  2005-10-10       Impact factor: 10.539

9.  Toll-like receptor ligands induce expression of the costimulatory molecule CD155 on antigen-presenting cells.

Authors:  Neha Kamran; Yoshimi Takai; Jun Miyoshi; Subhra K Biswas; Justin S B Wong; Stephan Gasser
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

10.  Expression and possible role of PVR/CD155/Necl-5 in osteoclastogenesis.

Authors:  Saori Kakehi; Ken-ichi Nakahama; Ikuo Morita
Journal:  Mol Cell Biochem       Date:  2007-02-08       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.